{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:14:51Z","timestamp":1789971291437,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["16-200545"],"award-info":[{"award-number":["16-200545"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001824","name":"Grantov\u00e1 Agentura \u010cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["GA14-29256S"],"award-info":[{"award-number":["GA14-29256S"]}],"id":[{"id":"10.13039\/501100001824","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["16\u201334238A"],"award-info":[{"award-number":["16\u201334238A"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003243","name":"Ministerstvo Zdravotnictv\u00ed Cesk\u00e9 Republiky","doi-asserted-by":"publisher","award":["LO1218"],"award-info":[{"award-number":["LO1218"]}],"id":[{"id":"10.13039\/501100003243","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001823","name":"Ministerstvo \u0160kolstv\u00ed, Ml\u00e1de\u017ee a T\u011blov\u00fdchovy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001823","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.antiviral.2016.07.018","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T11:19:08Z","timestamp":1469791148000},"page":"119-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"special_numbering":"C","title":["Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus"],"prefix":"10.1016","volume":"133","author":[{"given":"Lud\u011bk","family":"Eyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark\u00e9ta","family":"\u0160m\u00eddkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radim","family":"Nencka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji\u0159\u00ed","family":"Ne\u010da","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1\u0161","family":"Kastl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Palus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"De Clercq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"R\u016f\u017eek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2016.07.018_bib1","series-title":"Flavivirus Encephalitis","article-title":"Flaviviral infections and potential targets for antiviral therapy","author":"Baier","year":"2011"},{"key":"10.1016\/j.antiviral.2016.07.018_bib2","doi-asserted-by":"crossref","first-page":"4353","DOI":"10.1016\/S0021-9258(17)43053-5","article-title":"Neplanocin-a \u2013 a potent inhibitor of S-Adenosylhomocysteine hydrolase and of vaccinia virus multiplication in mouse L929 cells","volume":"259","author":"Borchardt","year":"1984","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.07.018_bib3","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1128\/JVI.76.7.3482-3492.2002","article-title":"Structural analysis of the hepatitis C virus RNA polymerase in complex with Ribonucleotides","volume":"76","author":"Bressanelli","year":"2002","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2016.07.018_bib4","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1128\/AAC.01152-10","article-title":"Antiviral efficacy upon administration of a HepDirect prodrug of 2 '-C-Methylcytidine to hepatitis C virus-infected chimpanzees","volume":"55","author":"Carroll","year":"2011","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.018_bib5","doi-asserted-by":"crossref","first-page":"11979","DOI":"10.1074\/jbc.M210914200","article-title":"Inhibition of hepatitis C virus RNA replication by 2 '-modified nucleoside analogs","volume":"278","author":"Carroll","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.07.018_bib6","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1128\/AAC.01032-08","article-title":"Robust antiviral efficacy upon administration of a nucleoside analog to hepatitis C virus-infected chimpanzees","volume":"53","author":"Carroll","year":"2009","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.018_bib7","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/1098-1128(200103)21:2<105::AID-MED1002>3.0.CO;2-U","article-title":"Adenosine deaminase: functional implications and different classes of inhibitors","volume":"21","author":"Cristalli","year":"2001","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.antiviral.2016.07.018_bib8","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1038\/nrmicro975","article-title":"Antivirals and antiviral strategies","volume":"2","author":"De Clercq","year":"2004","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.antiviral.2016.07.018_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-pharmtox-010510-100228","article-title":"A\u00a040-year journey in search of selective antiviral chemotherapy","volume":"51","author":"De Clercq","year":"2011","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"10.1016\/j.antiviral.2016.07.018_bib10","first-page":"53","article-title":"Antiviral agents acting as DNA or RNA chain terminators","volume":"189","author":"De Clercq","year":"2009"},{"key":"10.1016\/j.antiviral.2016.07.018_bib11","first-page":"113","article-title":"A\u00a0simple micro-culture method for study of group B arboviruses","volume":"40","author":"De Madrid","year":"1969","journal-title":"Bull. World Health Organ."},{"key":"10.1016\/j.antiviral.2016.07.018_bib12","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1086\/515195","article-title":"Tick-borne encephalitis","volume":"28","author":"Dumpis","year":"1999","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.07.018_bib13","doi-asserted-by":"crossref","first-page":"2283","DOI":"10.1021\/jm030424e","article-title":"Structure-activity relationship of purine ribonucleosides for inhibition of hepatitis C virus RNA-dependent RNA polymerase","volume":"47","author":"Eldrup","year":"2004","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.07.018_bib14","doi-asserted-by":"crossref","first-page":"5483","DOI":"10.1128\/AAC.00807-15","article-title":"Nucleoside inhibitors of tick-borne encephalitis virus","volume":"59","author":"Eyer","year":"2015","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.018_bib15","doi-asserted-by":"crossref","DOI":"10.1093\/infdis\/jiw226","article-title":"Nucleoside inhibitors of Zika virus","author":"Eyer","year":"2016","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.07.018_bib16","doi-asserted-by":"crossref","first-page":"3206","DOI":"10.1128\/AAC.02393-14","article-title":"Inhibitors of the tick-borne, hemorrhagic fever-associated flaviviruses","volume":"58","author":"Flint","year":"2014","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.018_bib17","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1699-0463.1993.tb00174.x","article-title":"The molecular-biology of tick-borne encephalitis-virus","volume":"101","author":"Heinz","year":"1993","journal-title":"Apmis"},{"key":"10.1016\/j.antiviral.2016.07.018_bib18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.3201\/eid1901.120458","article-title":"Vaccination and tick-borne encephalitis, central Europe","volume":"19","author":"Heinz","year":"2013","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.07.018_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.antiviral.2010.03.004","article-title":"Efficacy of 2 '-C-methylcytidine against yellow fever virus in cell culture and in a hamster model","volume":"86","author":"Julander","year":"2010","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.07.018_bib20","doi-asserted-by":"crossref","first-page":"3793","DOI":"10.1074\/jbc.M510195200","article-title":"The novel nucleoside analog R1479 (4 '-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture","volume":"281","author":"Klumpp","year":"2006","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.07.018_bib21","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1074\/jbc.M708929200","article-title":"2 '-deoxy-4 '-azido nucleoside analogs are highly potent inhibitors of hepatitis C virus replication despite the lack of 2 '-alpha-hydroxyl groups","volume":"283","author":"Klumpp","year":"2008","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.07.018_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/10409239309078440","article-title":"Evolution and taxonomy of positive-strand rna viruses \u2013 implications of comparative-analysis of amino-acid-sequences","volume":"28","author":"Koonin","year":"1993","journal-title":"Crit. Rev. Biochem. Mol. Biol."},{"key":"10.1016\/j.antiviral.2016.07.018_bib23","first-page":"498","article-title":"Pig kidney epithelial (ps) cells \u2013 perfect tool for study of flavi-viruses and some other arboviruses","volume":"19","author":"Kozuch","year":"1975","journal-title":"Acta Virol."},{"key":"10.1016\/j.antiviral.2016.07.018_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2015.01.002","article-title":"Characterization of the activity of 2 '-C-methylcytidine against dengue virus replication","volume":"116","author":"Lee","year":"2015","journal-title":"Antivir. Res."},{"key":"10.1016\/j.antiviral.2016.07.018_bib25","doi-asserted-by":"crossref","first-page":"29812","DOI":"10.1074\/jbc.M705274200","article-title":"Characterization of the metabolic activation of hepatitis C virus nucleoside inhibitor beta-D-2'-Deoxy-2'-fluoro-2'-C-methylcytidine (PSI-6130) and identification of a novel active 5'-triphosphate species","volume":"282","author":"Ma","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.07.018_bib26","doi-asserted-by":"crossref","first-page":"49164","DOI":"10.1074\/jbc.M305041200","article-title":"Characterization of resistance to non-obligate chain-terminating ribonucleoside analogs that inhibit hepatitis C virus replication in\u00a0vitro","volume":"278","author":"Migliaccio","year":"2003","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.antiviral.2016.07.018_bib27","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1128\/AAC.48.10.3944-3953.2004","article-title":"A\u00a07-deaza-adenosine analog is a potent and selective inhibitor of hepatitis C virus replication with excellent pharmacokinetic properties","volume":"48","author":"Olsen","year":"2004","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.018_bib28","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1128\/AAC.50.4.1320-1329.2006","article-title":"Triaryl pyrazoline compound inhibits flavivirus RNA replication","volume":"50","author":"Puig-Basagoiti","year":"2006","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.018_bib29","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.tmaid.2010.06.004","article-title":"Tick-borne encephalitis: pathogenesis and clinical implications","volume":"8","author":"Ruzek","year":"2010","journal-title":"Travel Med. Infect. Dis."},{"key":"10.1016\/j.antiviral.2016.07.018_bib30","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1099\/vir.0.010058-0","article-title":"Morphological changes in human neural cells following tick-borne encephalitis virus infection","volume":"90","author":"Ruzek","year":"2009","journal-title":"J.\u00a0General Virol."},{"key":"10.1016\/j.antiviral.2016.07.018_bib31","doi-asserted-by":"crossref","first-page":"2481","DOI":"10.1021\/jm201384j","article-title":"Nucleoside, nucleotide, and non-nucleoside inhibitors of hepatitis C virus NS5B RNA-dependent RNA-polymerase","volume":"55","author":"Sofia","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.antiviral.2016.07.018_bib32","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1128\/AAC.49.5.2050-2058.2005","article-title":"Inhibitory effect of 2'-substituted nucleosides on hepatitis C virus replication correlates with metabolic properties in replicon cells","volume":"49","author":"Tomassini","year":"2005","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.antiviral.2016.07.018_bib33","doi-asserted-by":"crossref","first-page":"362","DOI":"10.4161\/hv.22766","article-title":"Recommendations for tick-borne encephalitis vaccination from the central european vaccination awareness group (CEVAG)","volume":"9","author":"Zavadska","year":"2013","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.antiviral.2016.07.018_bib34","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.vetmic.2016.01.010","article-title":"Antiviral activities of 2,6-diaminopurine-based acyclic nucleoside phosphonates against herpesviruses: In\u00a0vitro study results with pseudorabies virus (PrV, SuHV-1)","volume":"184","author":"Zouharova","year":"2016","journal-title":"Veterinary Microbiol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300754?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216300754?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T05:50:52Z","timestamp":1656222652000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216300754"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":34,"alternative-id":["S0166354216300754"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.07.018","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structure-activity relationships of nucleoside analogues for inhibition of tick-borne encephalitis virus","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2016.07.018","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}